These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 18434308)
1. Crystal structures of F420-dependent glucose-6-phosphate dehydrogenase FGD1 involved in the activation of the anti-tuberculosis drug candidate PA-824 reveal the basis of coenzyme and substrate binding. Bashiri G; Squire CJ; Moreland NJ; Baker EN J Biol Chem; 2008 Jun; 283(25):17531-41. PubMed ID: 18434308 [TBL] [Abstract][Full Text] [Related]
2. Discovery and characterization of an F Nguyen QT; Trinco G; Binda C; Mattevi A; Fraaije MW Appl Microbiol Biotechnol; 2017 Apr; 101(7):2831-2842. PubMed ID: 27966048 [TBL] [Abstract][Full Text] [Related]
4. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Manjunatha UH; Boshoff H; Dowd CS; Zhang L; Albert TJ; Norton JE; Daniels L; Dick T; Pang SS; Barry CE Proc Natl Acad Sci U S A; 2006 Jan; 103(2):431-6. PubMed ID: 16387854 [TBL] [Abstract][Full Text] [Related]
5. Expression, purification and crystallization of native and selenomethionine labeled Mycobacterium tuberculosis FGD1 (Rv0407) using a Mycobacterium smegmatis expression system. Bashiri G; Squire CJ; Baker EN; Moreland NJ Protein Expr Purif; 2007 Jul; 54(1):38-44. PubMed ID: 17376702 [TBL] [Abstract][Full Text] [Related]
6. Molecular insights into the binding of coenzyme F420 to the conserved protein Rv1155 from Mycobacterium tuberculosis. Mashalidis EH; Gittis AG; Tomczak A; Abell C; Barry CE; Garboczi DN Protein Sci; 2015 May; 24(5):729-40. PubMed ID: 25644473 [TBL] [Abstract][Full Text] [Related]
7. Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liver. Dogra M; Palmer BD; Bashiri G; Tingle MD; Shinde SS; Anderson RF; O'Toole R; Baker EN; Denny WA; Helsby NA Br J Pharmacol; 2011 Jan; 162(1):226-36. PubMed ID: 20955364 [TBL] [Abstract][Full Text] [Related]
8. Rv0132c of Mycobacterium tuberculosis encodes a coenzyme F420-dependent hydroxymycolic acid dehydrogenase. Purwantini E; Mukhopadhyay B PLoS One; 2013; 8(12):e81985. PubMed ID: 24349169 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic insights into F Oyugi MA; Bashiri G; Baker EN; Johnson-Winters K Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):387-395. PubMed ID: 28807886 [TBL] [Abstract][Full Text] [Related]
10. F420H2 Is Required for Phthiocerol Dimycocerosate Synthesis in Mycobacteria. Purwantini E; Daniels L; Mukhopadhyay B J Bacteriol; 2016 Aug; 198(15):2020-8. PubMed ID: 27185825 [TBL] [Abstract][Full Text] [Related]
11. Structural Basis of allosteric regulation and substrate specificity of the non-phosphorylating glyceraldehyde 3-Phosphate dehydrogenase from Thermoproteus tenax. Lorentzen E; Hensel R; Knura T; Ahmed H; Pohl E J Mol Biol; 2004 Aug; 341(3):815-28. PubMed ID: 15288789 [TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis glucosyl-3-phosphoglycerate synthase: structure of a key enzyme in methylglucose lipopolysaccharide biosynthesis. Pereira PJ; Empadinhas N; Albuquerque L; Sá-Moura B; da Costa MS; Macedo-Ribeiro S PLoS One; 2008; 3(11):e3748. PubMed ID: 19015727 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis. Fujiwara M; Kawasaki M; Hariguchi N; Liu Y; Matsumoto M Tuberculosis (Edinb); 2018 Jan; 108():186-194. PubMed ID: 29523322 [TBL] [Abstract][Full Text] [Related]
14. Structural basis for substrate recognition of glucose-6-phosphate dehydrogenase from Kluyveromyces lactis. Vu HH; Jin C; Chang JH Biochem Biophys Res Commun; 2021 May; 553():85-91. PubMed ID: 33765558 [TBL] [Abstract][Full Text] [Related]
15. The crystal structures of ornithine carbamoyltransferase from Mycobacterium tuberculosis and its ternary complex with carbamoyl phosphate and L-norvaline reveal the enzyme's catalytic mechanism. Sankaranarayanan R; Cherney MM; Cherney LT; Garen CR; Moradian F; James MN J Mol Biol; 2008 Jan; 375(4):1052-63. PubMed ID: 18062991 [TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles. Gurumurthy M; Mukherjee T; Dowd CS; Singh R; Niyomrattanakit P; Tay JA; Nayyar A; Lee YS; Cherian J; Boshoff HI; Dick T; Barry CE; Manjunatha UH FEBS J; 2012 Jan; 279(1):113-25. PubMed ID: 22023140 [TBL] [Abstract][Full Text] [Related]
17. Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis. Haver HL; Chua A; Ghode P; Lakshminarayana SB; Singhal A; Mathema B; Wintjens R; Bifani P Antimicrob Agents Chemother; 2015 Sep; 59(9):5316-23. PubMed ID: 26100695 [TBL] [Abstract][Full Text] [Related]
18. Glucose-6-phosphate dehydrogenase and its 3D structures from crystallography and electron cryo-microscopy. Hanau S; Helliwell JR Acta Crystallogr F Struct Biol Commun; 2024 Oct; 80(Pt 10):236-251. PubMed ID: 39259139 [TBL] [Abstract][Full Text] [Related]
19. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Singh R; Manjunatha U; Boshoff HI; Ha YH; Niyomrattanakit P; Ledwidge R; Dowd CS; Lee IY; Kim P; Zhang L; Kang S; Keller TH; Jiricek J; Barry CE Science; 2008 Nov; 322(5906):1392-5. PubMed ID: 19039139 [TBL] [Abstract][Full Text] [Related]
20. The crystal structure of Rv2991 from Mycobacterium tuberculosis: An F Benini S; Haouz A; Proux F; Alzari P; Wilson K J Struct Biol; 2019 May; 206(2):216-224. PubMed ID: 30890426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]